Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
In biopharmaceutical manufacturing, strain identification is a core QC task that spans from the release of starting materials to investigations into contamination events. It actually comprises two closely related but conceptually distinct levels: species-level identification and strain-level typing.
The two are not alternatives but complementary. Understanding this distinction is the first step in choosing the right identification method.
Preparing release documentation for your cell bank? Creative Biogene offers one-stop strain identification services from species ID to strain-level typing, with complete validation packages and test reports supporting IND/BLA submissions.
No single method is perfect. When selecting a strain identification method, the core question is: what resolution do you need?
The resolution hierarchy of different methods: 16S rRNA sequencing resolves at the genus to species level; MLST (7-53 loci) achieves species to intra-species discrimination; and WGS or whole-genome MLST delivers the highest resolution at the strain level.
Complete comparison of six mainstream methods:
| Method | Principle | Resolution Level | Key Advantages | Key Limitations | Best For |
| 16S rRNA sequencing | Amplify & sequence ~1500 bp 16S gene | Genus to partial species | Broad universality, robust database | Poor discrimination of closely related species | MCB/WCB species ID |
| MALDI-TOF MS | Protein fingerprint vs. reference library | Species (library-dependent) | Fast (minutes), low cost | Library quality critical; limited for rare strains | High-throughput screening |
| MLST | Sequence 7+ housekeeping gene fragments | Species to strain level | Standardized, international database, inter-lab comparable | Higher cost (multiple PCR/seq reactions) | Strain typing, source tracking |
| WGS | Whole genome sequencing + ANI/SNP | Strain level (highest) | Highest resolution; full genomic view (resistome, virulence, evolution) | Higher cost; complex bioinformatics | Difficult ID, deep trace, proprietary strain |
| Ribotyping | Restriction digest of rRNA operon + fingerprint | Species to subspecies | Automated, standardized, high-throughput | Lower resolution than MLST/WGS | Large-scale screening, preliminary typing |
| Biochemical ID | Carbon source/enzyme activity | Genus to species | Classical, easy to standardize | Limited resolution; pure culture required | Routine microbial ID |
Turnaround times are typical; expedited service is available upon request.
All identification methods at Creative Biogene are internally validated, including primer specificity for 16S rDNA sequencing, database coverage for MALDI-TOF MS, and analysis pipelines for MLST/WGS. We provide complete validation documents and test reports as needed to support IND/BLA submissions for cell substrate characterization.
Per ICH Q5D Section 2.3, microbial cell banks must complete three mandatory tests: identity testing to confirm species identity using 16S rRNA sequencing or MALDI-TOF MS; purity testing to confirm the absence of non-target microorganisms via plate isolation, morphology, and molecular identification; and stability testing to assess genetic stability during MCB to WCB to EOP passage and define the acceptable passage limit.
Endotoxin testing is generally not a routine item for cell bank release unless required by risk assessment for specific applications.
Need a custom identification plan for your cell bank release? Our technical team will provide a tailored strain identification and compliance strategy based on your product type, strain characteristics, and regulatory stage.
Q: What are the specific ICH Q5D requirements for microbial cell bank identification?
Three mandatory tests: identity (confirm species), purity (no non-target microbes), and stability (genetic stability through passage limit). Endotoxin is generally not required unless for live biotherapeutic products, by risk assessment. Creative Biogene provides complete ICH Q5D-compliant testing packages with full validation documentation.
Q: How can I confirm whether multiple environmental isolates come from the same contamination source?
This is a strain-level typing question. We recommend MLST (standardized, international database comparable) or WGS (highest resolution via SNP analysis). Our bacterial typing platform has successfully handled numerous environmental monitoring and source tracking cases.
Q: What are the unique advantages of Creative Biogene in strain identification?
We have established a full-spectrum technical service platform: full-length 16S rRNA sequencing + MALDI-TOF MS dual-platform orthogonal verification, plus advanced typing methods such as rMLST (53 ribosomal loci), PFGE, RAPD, and WGS. All tests can be delivered with complete validation files and experimental records supporting IND/BLA submissions.
Copyright © 2026 Creative Biogene. All rights reserved.